Earlier age at menopause is associated with incident multimorbidity during later-life follow-up: a harmonized longitudinal analysis of three aging cohorts

Background Age at menopause is a clinically accessible marker of reproductive aging, but its relationship with first-onset multimorbidity during later-life follow-up remains insufficiently characterized. Methods We analyzed harmonized longitudinal data from the Health and Retirement Study (HRS), the English Longitudinal Study of Ageing (ELSA), and the Mexican Health and Aging Study (MHAS). A total of 6,576 women with an available age at menopause, no recorded hysterectomy by baseline, and zero or one of seven participant-reported physician-diagnosed chronic conditions at baseline were included. Menopause age was categorized as ≤40, 41–45, 46–49, 50–51, 52–53, and ≥54 years, with 50–51 years as the reference group. Incident multimorbidity was defined as the first follow-up assessment at which at least two of the seven conditions coexisted. Cox proportional hazards models with cohort-stratified baseline hazards were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results Among 6,576 women, 2,031 incident multimorbidity events occurred during 36,496.1 person-years of follow-up, with a mean follow-up of 5.55 years. In the fully adjusted pooled model, menopause at ≤40 years and 41–45 years was associated with higher risk than menopause at 50–51 years, with HRs of 1.218 (95% CI, 1.052–1.410) and 1.214 (95% CI, 1.050–1.404), respectively. Cohort-specific and sensitivity analyses generally supported the main findings. Conclusion Compared with menopause at 50–51 years, menopause at ≤40 or 41–45 years was associated with a higher risk of subsequently observed incident multimorbidity during later-life follow-up. Earlier menopausal timing may represent a useful life-course marker for identifying women at elevated risk of chronic disease accumulation in later life.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-16
DOI
https://doi.org/10.3389/fpubh.2026.1899024
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Earlier age at menopause is associated with incident multimorbidity during later-life follow-up: a harmonized longitudinal analysis of three aging cohorts

Jun-Jun Liu, Tao-Ming Dai, Yue-Yang Ma, Jie Yuan
8 links
Frontiers in Public Health
Menopause: Health Impacts and Treatments
article

Earlier age at menopause is associated with incident multimorbidity during later-life follow-up: a harmonized longitudinal analysis of three aging cohorts

Jun-Jun Liu, Tao-Ming Dai, Yue-Yang Ma, Jie Yuan
article en

Abstract

Background Age at menopause is a clinically accessible marker of reproductive aging, but its relationship with first-onset multimorbidity during later-life follow-up remains insufficiently characterized. Methods We analyzed harmonized longitudinal data from the Health and Retirement Study (HRS), the English Longitudinal Study of Ageing (ELSA), and the Mexican Health and Aging Study (MHAS). A total of 6,576 women with an available age at menopause, no recorded hysterectomy by baseline, and zero or one of seven participant-reported physician-diagnosed chronic conditions at baseline were included. Menopause age was categorized as ≤40, 41–45, 46–49, 50–51, 52–53, and ≥54 years, with 50–51 years as the reference group. Incident multimorbidity was defined as the first follow-up assessment at which at least two of the seven conditions coexisted. Cox proportional hazards models with cohort-stratified baseline hazards were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Results Among 6,576 women, 2,031 incident multimorbidity events occurred during 36,496.1 person-years of follow-up, with a mean follow-up of 5.55 years. In the fully adjusted pooled model, menopause at ≤40 years and 41–45 years was associated with higher risk than menopause at 50–51 years, with HRs of 1.218 (95% CI, 1.052–1.410) and 1.214 (95% CI, 1.050–1.404), respectively. Cohort-specific and sensitivity analyses generally supported the main findings. Conclusion Compared with menopause at 50–51 years, menopause at ≤40 or 41–45 years was associated with a higher risk of subsequently observed incident multimorbidity during later-life follow-up. Earlier menopausal timing may represent a useful life-course marker for identifying women at elevated risk of chronic disease accumulation in later life.

Frontiers in Public HealthVol. 14
Affiliated Hospital of Nantong University (CN), Yancheng Third People's Hospital (CN), Yancheng Vocational Institute of Industry Technology (CN)
Good health and well-being
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon